Jasper Therapeutics, Inc.

Amplitude Healthcare Acquisition Corporation, trading under the ticker AMHC and sponsored by Amplitude Healthcare LLC, is a blank-check company that completed its initial public offering in 2021 with a focus on the healthcare and biotechnology sector. The SPAC announced a definitive business combination agreement with Jasper Therapeutics, Inc., a clinical-stage biopharmaceutical company developing antibody-based conditioning therapies for hematopoietic stem cell transplantation. The 10-K/A filed on May 24, 2021, under accession number 0001213900-21-028779, represents an amendment to the entity's annual report on Form 10-K as registered with the SEC. Visit SpacDesk and sign up for full data, filings, and deal-level analytics on AMHC and hundreds of other active and historical SPACs.